Rajanarender Cholleti MD in Burleson, Texas

Medical School: Sorry, his university is not listed
Graduation Year: 1982
The Primary Medical Specialty for Rajanarender Cholleti MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 42
PAC (PECOS ID)#: 0648269456
NPI #: 1427012913
NPI Created On: 04/13/2006
NPI Last Updated Listed as: 01/25/2022
Primary Taxonomy Code: 174400000X
License Number:
209133
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Molina Marketplace
• Celtic Insurance Company
• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Hindi.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Routine ekg using at least 12 leads including interpretation and report
4. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
6. Heart rhythm tracing of 48-hour ekg
7. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
9. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
10. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
11. Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
12. New patient office or other outpatient visit, typically 45 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Initial hospital inpatient care, typically 50 minutes per day
16. Subsequent hospital inpatient care, typically 25 minutes per day
17. Technetium tc-99m tetrofosmin, diagnostic, per study dose
18. Injection, regadenoson, 0.1 mg